Medical Oncologist
Center for Multiple Myeloma, Massachusetts General Hospital, Harvard Medical School
Diana Cirstea, MD is a hematologist-oncologist at the Mass General Brigham Cancer Center, specializing in plasma cell disorders with a focus on T-cell redirecting therapies, including CAR T cells and T-cell engagers. She completed a Postdoctoral Research Fellowship at the Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute, followed by a Hematology/Oncology Fellowship at Boston Medical Center. Before joining Mass General Hospital, she spent over two years as a Bone Marrow Transplant and CAR T hospitalist at Dana-Farber and Brigham and Women's Hospital. Dr. Cirstea is a faculty member at Harvard Medical School and part of the Massachusetts General Hospital Multiple Myeloma Program. Her work is dedicated to advancing innovative immune-based treatments and expanding patient access to novel therapies.